| Date Filed | Type | Description |
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 06/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/02/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/02/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 03/31/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/31/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/15/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/07/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/07/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G/A
| T. Rowe Price Investment Management, Inc. reports a 14.2% stake in ESAB CORP |
| 02/13/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
SC 13G
| VANGUARD GROUP INC reports a 9.2% stake in Esab Corp. |
| 02/03/2023 |
SC 13G
| BlackRock Inc. reports a 7.4% stake in ESAB Corporation |
| 11/18/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Underwriting Agreement, among ESAB Corporation, Enovis Corporation, Goldman Sachs & Co. LLC, as selling stockholder, and Goldman Sachs & Co. LLC and Evercore Group L.L.C., as representatives of the several underwriters named therein",
"Underwriting Agreement, among ESAB Corporation, Enovis Corporation, Goldman Sachs & Co. LLC, as selling stockholder, and Goldman Sachs & Co. LLC and Evercore Group L.L.C., as representatives of the several underwriters named therein" |
|
| 11/17/2022 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 11/16/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/03/2022 |
8-K
| Quarterly results |
| 09/12/2022 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a |
| 09/12/2022 |
SC 13G
| T. Rowe Price Investment Management, Inc. reports a 10.4% stake in ESAB CORP |
| 08/18/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/09/2022 |
10-Q
| Quarterly Report for the period ended July 1, 2022 |
| 08/09/2022 |
8-K
| Quarterly results |
| 07/21/2022 |
8-K/A
| Quarterly results |
| 06/28/2022 |
8-K
| Quarterly results |
|